To explore this further, cisplatin resistance markers, including NFκB1, APEX1, MTDH, ERK1, and STAT3, were investigated in tumor cells that survived cisplatin cytotoxicity (Figure 5, Figure 6 and Figure 7, Supplementary Figures S8–S10). This evidence concerns the gene MAPK3 and neoplasm.